AJANTA PHARMA LIMITED (AJANTPHARM) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

AJANTPHARMUpdated 29 Aug 2026, 2:18

Ajanta Pharma Limited

Market Cap

₹44,484Cr.

Current Price

₹3,557

High / Low

₹3,797/2,330

Stock P/E

44.2

ROE24.0%
ROCE31.0%
Book Value₹338
Face Value₹2.00
Dividend Yield0.90%

About

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6581688687122105121105111104103
Inventory Days147167149290386240317278248229267286
Days Payable104128121193173166159120128130132160
Cash Conversion Cycle10812196183300195264279225210238229
Working Capital Days55837311513213213815392130116119
ROCE %60%55%48%33%25%27%34%30%21%32%33%31%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 29 August 2026 at 2:18


Designed & Shipped by Harshit Bansal